These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314 [TBL] [Abstract][Full Text] [Related]
7. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer. Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103 [TBL] [Abstract][Full Text] [Related]
8. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance. Alam M; Kashyap T; Mishra P; Panda AK; Nagini S; Mishra R Head Neck; 2019 Jan; 41(1):185-197. PubMed ID: 30549344 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019 [TBL] [Abstract][Full Text] [Related]
10. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
11. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. Alam M; Mishra R Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459 [TBL] [Abstract][Full Text] [Related]
12. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition. Kashyap T; Nath N; Mishra P; Jha A; Nagini S; Mishra R Head Neck; 2020 Nov; 42(11):3282-3294. PubMed ID: 32710593 [TBL] [Abstract][Full Text] [Related]
13. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028 [TBL] [Abstract][Full Text] [Related]
14. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells. Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866 [TBL] [Abstract][Full Text] [Related]
15. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC). Pramanik KK; Mishra R Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997 [TBL] [Abstract][Full Text] [Related]
16. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells. Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
18. Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. Naik PP; Mukhopadhyay S; Panda PK; Sinha N; Das CK; Mishra R; Patil S; Bhutia SK Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29171106 [TBL] [Abstract][Full Text] [Related]
19. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell. Huang M; Huang B; Li G; Zeng S BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838 [TBL] [Abstract][Full Text] [Related]
20. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]